# ONAPGO

NDC: 27505-006
Generic name: Apomorphine hydrochloride
Labeler / Manufacturer: MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20250204

FDA application: NDA214056

## Active ingredients

- APOMORPHINE HYDROCHLORIDE: 4.9 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"27505-006"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=27505-006
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f3552b6e-5ae7-4993-aa1a-e399c4a7080a